Cargando…
Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating instituti...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694237/ https://www.ncbi.nlm.nih.gov/pubmed/33158245 http://dx.doi.org/10.3390/cancers12113261 |
_version_ | 1783614931153715200 |
---|---|
author | Kim, Haeyoung Kim, Heejung Park, Won Baek, Jong Yun Ahn, Sung Ja Kim, Mi Young Park, Shin-Hyung Lee, Ik Jae Ha, Inbong Kim, Jin Hee Kim, Tae Hyun Lee, Kyu Chan Lee, Hyung-Sik Kim, Tae Gyu Kim, Jin Ho Lee, Jong Hoon Jung, Jinhong Cho, Oyeon Chang, Jee Suk Kim, Eun Seog Jo, In Young Koo, Taeryool Kim, Kyubo Park, Hae Jin Shin, Young-Joo Ha, Boram Kwon, Jeanny Lee, Ju Hye Moon, Sunrock |
author_facet | Kim, Haeyoung Kim, Heejung Park, Won Baek, Jong Yun Ahn, Sung Ja Kim, Mi Young Park, Shin-Hyung Lee, Ik Jae Ha, Inbong Kim, Jin Hee Kim, Tae Hyun Lee, Kyu Chan Lee, Hyung-Sik Kim, Tae Gyu Kim, Jin Ho Lee, Jong Hoon Jung, Jinhong Cho, Oyeon Chang, Jee Suk Kim, Eun Seog Jo, In Young Koo, Taeryool Kim, Kyubo Park, Hae Jin Shin, Young-Joo Ha, Boram Kwon, Jeanny Lee, Ju Hye Moon, Sunrock |
author_sort | Kim, Haeyoung |
collection | PubMed |
description | SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. In all RLN regions including supraclavicular lymph node, axillary lymph node, and internal mammary lymph node, the radiation dose to the RLN was higher in WBI+RNI plan than WBI plan. ABSTRACT: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. To compare target coverage between the participants, an isodose line equal to 90% of the prescribed dose was converted to an isodose contour (contour(90% iso))(.) The relative nodal dose (RND) was obtained using the ratio of RLN dose to the target dose. The Fleiss’s kappa values which represent inter-observer agreement of contour(90% iso) were over 0.68. For RNI, 6 institutions included axillary lymph node (ALN), supraclavicular lymph node (SCN), and internal mammary lymph node (IMN), while 18 hospitals included only ALN and SCN. The median RND between the WBI and WBI+RNI were as follows: 0.64 vs. 1.05 (ALN level I), 0.27 vs. 1.08 (ALN level II), 0.02 vs. 1.12 (ALN level III), 0.01 vs. 1.12 (SCN), and 0.54 vs. 0.82 (IMN). In all nodal regions, the RND was significantly lower in WBI than in WBI+RNI (p < 0.01). In this study, we could identify the nodal dose difference between WBI and WBI+RNI. |
format | Online Article Text |
id | pubmed-7694237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76942372020-11-28 Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) Kim, Haeyoung Kim, Heejung Park, Won Baek, Jong Yun Ahn, Sung Ja Kim, Mi Young Park, Shin-Hyung Lee, Ik Jae Ha, Inbong Kim, Jin Hee Kim, Tae Hyun Lee, Kyu Chan Lee, Hyung-Sik Kim, Tae Gyu Kim, Jin Ho Lee, Jong Hoon Jung, Jinhong Cho, Oyeon Chang, Jee Suk Kim, Eun Seog Jo, In Young Koo, Taeryool Kim, Kyubo Park, Hae Jin Shin, Young-Joo Ha, Boram Kwon, Jeanny Lee, Ju Hye Moon, Sunrock Cancers (Basel) Article SIMPLE SUMMARY: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. In all RLN regions including supraclavicular lymph node, axillary lymph node, and internal mammary lymph node, the radiation dose to the RLN was higher in WBI+RNI plan than WBI plan. ABSTRACT: The purpose of the current in silico planning study is to compare radiation doses of whole-breast irradiation (WBI) and whole-breast plus regional lymph node irradiation (WBI+RNI) administered to the regional lymph nodes (RLN) in pN1 breast cancer. Twenty-four participating institutions were asked to create plans of WBI and WBI+RNI for two dummy cases. To compare target coverage between the participants, an isodose line equal to 90% of the prescribed dose was converted to an isodose contour (contour(90% iso))(.) The relative nodal dose (RND) was obtained using the ratio of RLN dose to the target dose. The Fleiss’s kappa values which represent inter-observer agreement of contour(90% iso) were over 0.68. For RNI, 6 institutions included axillary lymph node (ALN), supraclavicular lymph node (SCN), and internal mammary lymph node (IMN), while 18 hospitals included only ALN and SCN. The median RND between the WBI and WBI+RNI were as follows: 0.64 vs. 1.05 (ALN level I), 0.27 vs. 1.08 (ALN level II), 0.02 vs. 1.12 (ALN level III), 0.01 vs. 1.12 (SCN), and 0.54 vs. 0.82 (IMN). In all nodal regions, the RND was significantly lower in WBI than in WBI+RNI (p < 0.01). In this study, we could identify the nodal dose difference between WBI and WBI+RNI. MDPI 2020-11-04 /pmc/articles/PMC7694237/ /pubmed/33158245 http://dx.doi.org/10.3390/cancers12113261 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Haeyoung Kim, Heejung Park, Won Baek, Jong Yun Ahn, Sung Ja Kim, Mi Young Park, Shin-Hyung Lee, Ik Jae Ha, Inbong Kim, Jin Hee Kim, Tae Hyun Lee, Kyu Chan Lee, Hyung-Sik Kim, Tae Gyu Kim, Jin Ho Lee, Jong Hoon Jung, Jinhong Cho, Oyeon Chang, Jee Suk Kim, Eun Seog Jo, In Young Koo, Taeryool Kim, Kyubo Park, Hae Jin Shin, Young-Joo Ha, Boram Kwon, Jeanny Lee, Ju Hye Moon, Sunrock Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title | Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title_full | Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title_fullStr | Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title_full_unstemmed | Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title_short | Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701) |
title_sort | comparison of dose distribution in regional lymph nodes in whole-breast radiotherapy vs. whole-breast plus regional lymph node irradiation: an in silico planning study in participating institutions of the phase iii randomized trial (krog 1701) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694237/ https://www.ncbi.nlm.nih.gov/pubmed/33158245 http://dx.doi.org/10.3390/cancers12113261 |
work_keys_str_mv | AT kimhaeyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimheejung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT parkwon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT baekjongyun comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT ahnsungja comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimmiyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT parkshinhyung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT leeikjae comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT hainbong comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimjinhee comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimtaehyun comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT leekyuchan comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT leehyungsik comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimtaegyu comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimjinho comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT leejonghoon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT jungjinhong comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT chooyeon comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT changjeesuk comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimeunseog comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT joinyoung comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kootaeryool comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kimkyubo comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT parkhaejin comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT shinyoungjoo comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT haboram comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT kwonjeanny comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT leejuhye comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 AT moonsunrock comparisonofdosedistributioninregionallymphnodesinwholebreastradiotherapyvswholebreastplusregionallymphnodeirradiationaninsilicoplanningstudyinparticipatinginstitutionsofthephaseiiirandomizedtrialkrog1701 |